Cargando…
Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
BACKGROUND: Gastrointestinal harm, known to occur with NSAIDs, is thought to be lower with NSAID and gastroprotective agent, and with inhibitors selective to cyclooxygenase-2 (coxibs) at usual plasma concentrations. We examine competing strategies for available evidence of reduced gastrointestinal b...
Autores principales: | Moore, R Andrew, Derry, Sheena, Phillips, Ceri J, McQuay, Henry J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1626078/ https://www.ncbi.nlm.nih.gov/pubmed/17054784 http://dx.doi.org/10.1186/1471-2474-7-79 |
Ejemplares similares
-
Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk
por: Moore, R Andrew, et al.
Publicado: (2007) -
Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
por: Straube, Sebastian, et al.
Publicado: (2009) -
Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes
por: Moore, R Andrew, et al.
Publicado: (2008) -
Topical NSAIDs for acute pain: a meta-analysis
por: Mason, Lorna, et al.
Publicado: (2004) -
Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis
por: Mason, Lorna, et al.
Publicado: (2004)